Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status.
<h4>Objectives</h4>Monitoring of SARS-CoV-2 spread and vaccination strategies have relied on antibody (Ab) status as a correlate of protection. We used QuantiFERON™ (QFN) and Activation-Induced Marker (AIM) assays to measure memory T-cell reactivity in unvaccinated individuals with prior...
Main Authors: | Arianna Gatti, Gaetano Zizzo, Massimo De Paschale, Antonio Tamburello, Laura Castelnovo, Paola Maria Faggioli, Pierangelo Clerici, Bruno Brando, Antonino Mazzone |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0285728 |
Similar Items
-
Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status
by: Arianna Gatti, et al.
Published: (2023-01-01) -
Comparison of LIAISON QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold Plus
by: Kamran Kadkhoda, et al.
Published: (2023-02-01) -
Frequency and Factors of Indeterminate QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold PLUS Test Results in Rheumatic Diseases
by: Sung Soo Ahn, et al.
Published: (2021-09-01) -
QuantiFERON-TB reversion in children and adolescents with tuberculosis
by: Paula Rodríguez-Molino, et al.
Published: (2024-03-01) -
Improved Performance of the QuantiFERON-SARS-CoV-2 Assay with the Extended Set
by: Lydia Lamara Mahammed, et al.
Published: (2023-05-01)